NCATS chemical screening resources enable studies on potential treatments for Parkinson's and related diseases.
NCATS researchers provided crucial pre-clinical resources for Aes-103, a potential therapeutic to treat sickle cell disease.
NCATS scientists exploring the lipoxygenase enzyme family have enabled development of three chemical probes with the potential to treat diabetes, stroke and thrombosis.
NCATS scientists propose grouping rare disease patients by the shared genetic characteristics of their diseases, enabling more targeted treatment.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
Innovative networks streamline research protocol review and approval.
- Study Details Risk Factors for Substance Use Disorders after Manic Episode • University of Cincinnati
- Trail Blazers: Metabolites Map Biological Processes in All Living Things • University of Florida, Explore
- New KL2 Scholars Tackle Diabetes, Radiation Safety and Depression • Duke Translational Medicine Institute
- More News & Events...